COVID-19 is causing less severe illness on average than it did in 2020 and 2021, but the reason is more complicated than the virus simply becoming weaker. The drop in severity is largely driven by widespread immunity from vaccines, prior infections, or both. The virus itself has not followed a predictable path toward mildness, and for certain groups, it remains dangerous.
What the Hospitalization Numbers Show
When Omicron replaced Delta as the dominant variant in early 2022, the picture changed noticeably for hospitalized adults. Compared to the Delta period, a smaller percentage of hospitalizations during Omicron were primarily caused by COVID (87.5% versus 95.5%). Hospital stays were shorter, with a median of four days compared to five. The proportion of patients admitted to intensive care, placed on ventilators, or dying in the hospital all dropped significantly.
That said, Omicron was so contagious that it still overwhelmed hospitals. Weekly hospitalization rates among adults peaked at 38.4 per 100,000 during Omicron, more than double the Delta peak of 15.5. A milder virus that infects far more people can still cause enormous damage in absolute numbers. The per-case severity dropped, but the total burden on hospitals did not.
The Virus Hasn’t Steadily Weakened
There’s a popular assumption that viruses always evolve to become less dangerous. COVID hasn’t followed that script. A study tracking the intrinsic severity of each major variant, after adjusting for immunity and other factors, found that the direction of severity changes was inconsistent. Alpha was roughly 50% more severe than the strain it replaced. Delta was about twice as severe as Alpha. Omicron then appeared to be less severe than Delta, but the jump from Alpha to Delta shows the virus can become more dangerous, not just less.
The researchers concluded that the intrinsic severity of future variants remains uncertain, and that a more severe variant emerging is entirely plausible. What’s protected populations so far isn’t a friendlier virus. It’s the immune memory built up across billions of people through infection, vaccination, or both.
Immunity Is Doing the Heavy Lifting
The single biggest reason COVID outcomes have improved is that almost no one’s immune system is encountering the virus for the first time anymore. A large Israeli study tracked 1.2 million people aged 60 and older over two years (2022 to 2024) and found that individuals without a prior documented infection were 14.4 times more at risk of severe disease compared to those with hybrid immunity, meaning they had been both vaccinated and previously infected.
During the Omicron peak in January 2022, unvaccinated adults were hospitalized at 12 times the rate of vaccinated adults who had received a booster dose. Even compared to people who had a primary vaccine series but no booster, unvaccinated adults were hospitalized at four times the rate. The gap between protected and unprotected was enormous, and it explains much of the apparent “mildness” of newer waves.
Children Haven’t Seen the Same Improvement
One of the more surprising findings involves children under five. A U.S. study of over 10,000 hospitalized children across three variant periods (pre-Delta, Delta, and Omicron) found no statistically significant differences in severity. About 21% of hospitalized children were admitted to the ICU regardless of which variant was circulating. The need for supplemental oxygen was similar (13% to 18%), as was the use of mechanical ventilation (7% to 8%). The median hospital stay was two days across all three periods.
In-hospital deaths were rare in all periods, ranging from 0.4% to 0.9%, with the lowest rate during Omicron. But the overall pattern suggests that for very young children who do end up hospitalized, the severity of illness has not meaningfully changed with newer variants.
Long COVID Risk Has Dropped, but Not Disappeared
The chance of developing long-lasting symptoms after infection has decreased with newer variants. A meta-analysis of 35 studies covering about 159,000 people across 19 countries found the pooled prevalence of long COVID was 35.5% in the pre-Omicron era and 22.8% during the Omicron period. That’s a meaningful decline, but it still means roughly one in four or five people infected during the Omicron era reported persistent symptoms.
The variation between waves was also striking. The Beta wave had the highest long COVID prevalence at nearly 60%, while the original wild-type strain had the lowest at about 18%. These numbers reinforce the broader point: the trajectory hasn’t been a straight line downward.
Symptoms Have Shifted
The way COVID feels has changed as the virus has evolved. The incubation period has shortened noticeably. Early in the pandemic, the average time from exposure to symptoms was about 6.5 days. With Delta, it dropped to around 4.3 days, and with Omicron, it fell further to 3 to 4 days. Loss of smell and taste, once a hallmark of infection, became much less common once Omicron variants took over.
For most people today, a COVID infection feels more like a bad cold or flu: sore throat, congestion, fatigue, body aches. That’s a genuine shift from the early pandemic, when pneumonia and severe breathing problems were far more common in even middle-aged, otherwise healthy adults.
Who’s Still at Serious Risk
Age remains the strongest risk factor for severe COVID outcomes. Risk increases substantially after 65. People with underlying medical conditions face elevated risk at any age, and being unvaccinated or behind on boosters compounds the danger. Long-term care facility residents, who make up less than 1% of the U.S. population, have accounted for more than 35% of all COVID deaths.
Racial and ethnic disparities persist as well. People from minority groups are more likely to be hospitalized, admitted to the ICU, and die from COVID at younger ages compared to non-Hispanic white people. These gaps reflect longstanding differences in access to care, prevalence of underlying conditions, and occupational exposure.
For someone who is young, vaccinated, and has been infected before, COVID in 2025 is a genuinely milder experience than it was in 2020. But that mildness is not a fixed property of the virus. It’s a product of the immunity your body has built. If a substantially different variant emerged and evaded that immunity, the calculus could change. The virus hasn’t promised to keep getting weaker. Your immune system is what’s keeping the upper hand.